Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Di Guglielmo Disease

epirubicin has been researched along with Di Guglielmo Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ju, RJ; Li, N; Li, RJ; Lu, WL; Men, Y; Tian, W; Wang, XX; Yao, HJ; Ying, X; Yu, Y; Zhang, L; Zhang, Y; Zhou, J1
Cao, YH; Chang, HY; Huang, Y; Jiao, XY; Liu, JH; Ma, FC; Pan, KL; Zhu, HF1
Hu, X; Pan, Q; Zheng, S1
Chen, WY; Hu, X2
Borrel, MN; Fiallo, M; Garnier-Suillerot, A; Priebe, W1

Other Studies

6 other study(ies) available for epirubicin and Di Guglielmo Disease

ArticleYear
The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Amlodipine; Analysis of Variance; Animals; Antibiotics, Antineoplastic; Caspase 3; Caspase 9; Cell Survival; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Xenograft Model Antitumor Assays

2011
[The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2006, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cell Survival; Curcumin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Erythromycin; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; K562 Cells; Leukemia, Erythroblastic, Acute; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2006
[Reduced intracellular drug accumulation related to overexpression of P-glycoprotein cannot explain the complete drug resistance in MDR cell variant K562/Dox].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured

1995
Restoration of intracellular drug accumulation in MDR cell line K562r does not mean reversal of its drug resistance.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured

1994
P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
    FEBS letters, 1994, Dec-19, Volume: 356, Issue:2-3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Clone Cells; Doxorubicin; Drug Resistance; Epirubicin; Glucose; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Structure; Tumor Cells, Cultured

1994
[Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:3

    Topics: Antibiotics, Antineoplastic; Cell Nucleus; Chromatography, High Pressure Liquid; Cytoplasm; Daunorubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured; Verapamil

1994